WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001030800) ANTISENSE MODULATION OF Y-BOX BINDING PROTEIN 1 EXPRESSION
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2001/030800 International Application No.: PCT/US2000/029089
Publication Date: 03.05.2001 International Filing Date: 20.10.2000
Chapter 2 Demand Filed: 21.05.2001
IPC:
A61K 38/00 (2006.01) ,C12N 15/11 (2006.01) ,C12Q 1/68 (2006.01)
Applicants: BENNETT, C., Frank[US/US]; US (UsOnly)
COWSERT, Lex, M.[US/US]; US (UsOnly)
ISIS PHARMACEUTICALS, INC.[US/US]; 2292 Faraday Avenue Carlsbad, CA 92008, US (AllExceptUS)
Inventors: BENNETT, C., Frank; US
COWSERT, Lex, M.; US
Agent: LICATA, Jane, Massey ; Law Offices of Jane Massey Licata 66 E. Main Street Marlton, NJ 08053, US
Priority Data:
09/429,32326.10.1999US
Title (EN) ANTISENSE MODULATION OF Y-BOX BINDING PROTEIN 1 EXPRESSION
(FR) MODULATION ANTISENS DE L'EXPRESSION DE LA PROTEINE 1 DE LIAISON DE BOITE Y
Abstract:
(EN) Antisense compounds, compositions and methods are provided for modulating the expression of Y-box binding protein 1. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Y-box binding protein 1. Methods of using these compounds for modulation of Y-box binding protein 1 expression and for treatment of diseases associated with expression of Y-box binding protein 1 are provided.
(FR) La présente invention concerne des composés antisens, des compositions et des procédés permettant de moduler l'expression de la protéine 1 de liaison de boîte Y. Lesdites compositions comprennent des composés antisens, notamment des oligonucléotides antisens, ciblés sur des acides nucléiques codant la protéine 1 de liaison de boîte Y. La présente invention concerne également des procédés d'utilisation de ces composés pour la modulation de l'expression de la protéine 1 de liaison de boîte Y et pour le traitement de maladies liées à l'expression de la protéine 1 de liaison de boîte Y.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)